Intuitive Surgical (NASDAQ:ISRG) Reaches New 12-Month High – What’s Next?

Intuitive Surgical, Inc. (NASDAQ:ISRG) reached a new 52-week high on Wednesday . The company traded as high as $562.00 and last traded at $558.46, with a volume of 163335 shares trading hands. The stock had previously closed at $538.88.

Analyst Upgrades and Downgrades

A number of research firms have weighed in on ISRG. Stifel Nicolaus raised their price target on Intuitive Surgical from $525.00 to $610.00 and gave the company a “buy” rating in a research report on Thursday, December 5th. Citigroup raised their price target on Intuitive Surgical from $567.00 to $640.00 and gave the company a “buy” rating in a research report on Wednesday, December 11th. Erste Group Bank upgraded Intuitive Surgical from a “hold” rating to a “buy” rating in a research report on Tuesday, November 19th. The Goldman Sachs Group set a $604.00 price objective on Intuitive Surgical in a research note on Friday, October 18th. Finally, Leerink Partners raised their price objective on Intuitive Surgical from $489.00 to $502.00 in a research note on Thursday, October 17th. One equities research analyst has rated the stock with a sell rating, four have assigned a hold rating and fifteen have issued a buy rating to the stock. According to data from MarketBeat, the company has a consensus rating of “Moderate Buy” and an average target price of $554.17.

Intuitive Surgical Stock Up 6.4 %

The company’s fifty day moving average price is $537.05 and its 200-day moving average price is $496.50. The stock has a market capitalization of $204.13 billion, a PE ratio of 92.14, a price-to-earnings-growth ratio of 5.31 and a beta of 1.39.

Intuitive Surgical (NASDAQ:ISRG) last announced its quarterly earnings data on Thursday, October 17th. The medical equipment provider reported $1.56 earnings per share for the quarter, topping analysts’ consensus estimates of $1.24 by $0.32. Intuitive Surgical had a net margin of 28.51% and a return on equity of 13.41%. The company had revenue of $2.04 billion during the quarter, compared to analyst estimates of $2.01 billion. Equities research analysts anticipate that Intuitive Surgical, Inc. will post 5.45 earnings per share for the current year.

Insider Buying and Selling

In related news, CEO Gary S. Guthart sold 18,151 shares of the company’s stock in a transaction on Wednesday, October 30th. The shares were sold at an average price of $511.63, for a total value of $9,286,596.13. Following the completion of the transaction, the chief executive officer now owns 24,219 shares of the company’s stock, valued at approximately $12,391,166.97. This represents a 42.84 % decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through this link. Also, SVP Mark Brosius sold 2,128 shares of the business’s stock in a transaction on Tuesday, October 22nd. The stock was sold at an average price of $515.00, for a total transaction of $1,095,920.00. Following the completion of the sale, the senior vice president now owns 273 shares in the company, valued at approximately $140,595. The trade was a 88.63 % decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 48,190 shares of company stock worth $25,012,927 in the last three months. Insiders own 0.90% of the company’s stock.

Hedge Funds Weigh In On Intuitive Surgical

Several hedge funds have recently added to or reduced their stakes in ISRG. Hazlett Burt & Watson Inc. raised its stake in shares of Intuitive Surgical by 5.8% during the third quarter. Hazlett Burt & Watson Inc. now owns 362 shares of the medical equipment provider’s stock valued at $177,000 after acquiring an additional 20 shares in the last quarter. Mitchell Mcleod Pugh & Williams Inc. grew its holdings in shares of Intuitive Surgical by 4.1% during the third quarter. Mitchell Mcleod Pugh & Williams Inc. now owns 503 shares of the medical equipment provider’s stock valued at $247,000 after buying an additional 20 shares during the last quarter. Fragasso Financial Advisors Inc grew its holdings in shares of Intuitive Surgical by 3.0% during the fourth quarter. Fragasso Financial Advisors Inc now owns 687 shares of the medical equipment provider’s stock valued at $359,000 after buying an additional 20 shares during the last quarter. Ullmann Wealth Partners Group LLC lifted its position in Intuitive Surgical by 1.6% during the third quarter. Ullmann Wealth Partners Group LLC now owns 1,329 shares of the medical equipment provider’s stock valued at $653,000 after purchasing an additional 21 shares during the period. Finally, Meeder Advisory Services Inc. lifted its position in Intuitive Surgical by 0.3% during the third quarter. Meeder Advisory Services Inc. now owns 7,386 shares of the medical equipment provider’s stock valued at $3,629,000 after purchasing an additional 22 shares during the period. 83.64% of the stock is currently owned by institutional investors.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.